Wire Stories
-
661Lyre�s Non-Alcoholic Spirits Secures $11.5 Million in Seed Funding
Leader in the Non-Alcoholic Category Prepares to Launch Ready-To-Drink Range and Responds to Changing Consumer Demand LOS ANGELES–(BUSINESS WIRE)–Lyre�s Non-Alcoholic Spirit Co.,...
-
720
Digital Legal Exchange Joins TechLaw.Fest as Digital Transformation Partner
Exchange faculty to join a host of thought leaders and innovators at the largest-ever TechLaw.Fest LONDON–(BUSINESS WIRE)–The Digital Legal Exchange (DLEX), a...
-
632
Alchemy Pay to Integrate Chainlink Price Feeds to Power DeFi Products and Fair Crypto Payments
SINGAPORE–(BUSINESS WIRE)–Alchemy Pay, a pioneer in hybrid digital and fiat payment solutions, is integrating Chainlink�s Price Feeds to help power DeFi products...
-
679
Jumio Named a Representative Vendor in the Gartner Market Guide for Identity Proofing and Attribution for Third Consecutive Year
Report expects that by 2022, 80% of organizations will use document-centric identity proofing as part of their onboarding workflows, an increase from...
-
714
Arista Announces Acquisition of Awake Security
AI-driven network detection and response for client to cloud network security SANTA CLARA, Calif.–(BUSINESS WIRE)–Arista Networks (NYSE:ANET), a leader in cognitive cloud...
-
875
Epic Fantasy 3DMMORPG Forsaken World: Gods and Demons Open for Pre-registration Today
A magical MMORPG world with a storyline of epic proportions SHANGHAI–(BUSINESS WIRE)–#Calindor–Forsaken World: Gods and Demons is an open-world fantasy MMORPG on...
-
637
Beijing Fourth Intermediate People�s Court Issues Judgement Against Sinobioway Medicine and Mr. Aihua Pan
BEIJING–(BUSINESS WIRE)–Sinovac Biotech Ltd. (NASDAQ:SVA) (�Sinovac� or the �Company�), a leading provider of biopharmaceutical products in China, announced today that the Fourth...
-
660
Beijing Fourth Intermediate People�s Court Issues Judgement Against Sinobioway Medicine and Mr. Aihua Pan
BEIJING–(BUSINESS WIRE)–Sinovac Biotech Ltd. (NASDAQ:SVA) (�Sinovac� or the �Company�), a leading provider of biopharmaceutical products in China, announced today that the Fourth...
-
665
Shionogi Announces FDA Approval of FETROJA� (cefiderocol) for the Treatment of Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia
OSAKA, Japan & FLORHAM PARK, N.J.–(BUSINESS WIRE)–Shionogi & Co., Ltd. (hereafter �Shionogi�) today announces that the U.S. Food and Drug Administration (FDA)...
-
659
2020 Taiwan Innotech Forum Focuses on IP Strategies in Post-Pandemic Era
TAIPEI, Taiwan–(BUSINESS WIRE)–#5plus2–Intellectual Property (IP) constitutes the foundation in protecting an enterprise’s R&D and innovation. It is also an important mechanism in...
